Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

Abstract Background Although immune checkpoint inhibitor (ICI) is regarded as a breakthrough in cancer therapy, only a limited fraction of patients benefit from it. Cancer stemness can be the potential culprit in ICI resistance, but direct clinical evidence is lacking. Methods Publicly available scR...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhen Zhang, Zi-Xian Wang, Yan-Xing Chen, Hao-Xiang Wu, Ling Yin, Qi Zhao, Hui-Yan Luo, Zhao-Lei Zeng, Miao-Zhen Qiu, Rui-Hua Xu
Format: Artigo
Idioma:Inglês
Publicat: BMC 2022-04-01
Col·lecció:Genome Medicine
Matèries:
Big data analysis
Single-cell sequencing
Immune checkpoint therapy
Stemness
Pan-cancer
Accés en línia:https://doi.org/10.1186/s13073-022-01050-w
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars